Financials

Financials — What the Numbers Say

Marex is a global commodity-and-financial-services broker that intermediates client trading on more than 60 exchanges. Revenue compounded ~25% per year since 2020 to $2.0B in FY2025, profit margins have roughly doubled, and the company has just reported its eighth consecutive quarter of year-on-year profit growth as a public company on top of an 11-year private record. Reported earnings convert into cash, but operating cash flow is genuinely lumpy because most of the balance sheet is client money — total assets of $34.7B sit on $1.3B of equity, an A/E ratio of ~27x that is normal for a clearing broker but invites confusion. The stock prices around 9–13x earnings versus a 27% ROE and 27% revenue growth — cheap on quality, but the market is implying that 2025-2026's volatility-fuelled trading windfall normalises. The single financial metric that matters next is segment-mix margin — specifically whether Agency & Execution can sustain the ~27% Adjusted PBT margin Prime Services drove in FY2025 once volatility moderates.

Financials in One Page

A note on terminology used throughout this page:

• Free cash flow (FCF) is operating cash flow minus capital expenditures — the cash a business generates after running and maintaining itself.
• ROE / ROIC are how efficiently each dollar of shareholder equity / total invested capital throws off profit.
• Net interest income (NII) is the spread Marex earns by holding cash on behalf of clients (mostly invested in government securities) net of its own debt funding cost — the same line item a bank reports.
• Adjusted Profit Before Tax is Marex's preferred non-IFRS metric: reported PBT plus add-backs for amortisation of acquired intangibles and one-off acquisition costs. It is not GAAP, but it is what management guides on.

A Quality Score and Fair Value gap are not yet published for Marex (the company IPO'd in April 2024 and the standardised quality models do not yet cover it), so the verdicts below lean on directly observable cash flow, returns on capital, and peer-relative valuation.

Revenue, Margins, and Earnings Power

Revenue is built from four segments — Clearing, Agency & Execution (the largest), Market Making, and Hedging & Investment Solutions. The income statement strips this back to four line items: net commission income (the fee for executing/clearing a trade), net trading income (gains on principal positions in market-making and structured products), net interest income (yield on client cash less funding costs), and net physical commodities income (margin on physical metals/energy flowing through the books).

The shape that matters: revenue is up ~3.6x in five years, operating income up ~10x, and net income up ~7x. The 2021 revenue dip looks like a slowdown but is actually a presentation change (commission expense was netted against revenue starting that year). What is real is the operating leverage — every line of incremental revenue from FY2022 onward dropped a higher proportion to profit, and acquisitions (Aarna, Hamilton Court, Winterflood, Agrinvest in 2025) added a structural step-up.

Margins have inflected from "skinny broker" levels (sub-5% net) to best-in-class capital-markets levels (14.5% net, 19.8% operating). Two engines drove the lift: net interest income from elevated client balances during the high-rate cycle, and the scaling of higher-margin Prime Services and structured products inside Agency & Execution and Solutions. The risk: as the Fed Funds rate has fallen ~100 bps and a further ~70 bps year-over-year through Q1 2026, the NII tailwind reverses (NII fell 33% in FY2025 and another 23% in Q1 2026 vs. prior-year period). The fact that group margin still expanded 180 bps in FY2025 and 60 bps in Q1 2026 is the proof that fee and trading income now carry the franchise.

Quarterly revenue has grown sequentially in every period since IPO and the Q1 2026 print of $692M (+48% YoY) is the largest quarterly absolute jump on record, helped by exceptional Q1 volatility (Middle East energy, metals dislocation) and the consolidation of Winterflood. Earnings power is improving, not normalising — but Q1 included a one-time benefit from extreme market conditions that management explicitly said it does not expect to persist.

Cash Flow and Earnings Quality

For most companies, comparing net income to operating cash flow is a clean test of earnings quality. For Marex it is misleading without a caveat. Operating cash flow includes the change in client money held on the balance sheet — when clearing client balances rise (more client positions or higher margin requirements), reported OCF surges; when balances fall, OCF drops. The $1.16B OCF in FY2024 and the $668M in FY2025 are both real numbers but not directly comparable to the underlying earnings engine.

The structural picture is unambiguous: from FY2022 onward, operating cash flow has consistently exceeded pretax income (sometimes by 2-5x) because client deposits keep rising and capex is essentially zero — only $13M in FY2025 against $2.0B of revenue. Free cash flow tracks operating cash flow almost line-for-line because the business is asset-light at the parent level (people, technology, exchange seats — no factories, no inventory).

Cash-flow distortion	FY2024	FY2025	Comment
Capex (% of revenue)	0.7%	0.6%	Marex is asset-light — fixed-cost inflation is people, not plant
Stock-based compensation ($M)	30	44	Material but not yet dilutive (~2% of revenue)
Acquisitions ($M)	11	242	Heavy 2025 deal year (Hamilton Court, Winterflood, Agrinvest, Aarna)
Dividends paid ($M)	77	56	Steady payout; raised $0.16/share quarterly into Q1 2026
Buybacks ($M)	20	44	Modest — capital prioritised toward M&A and balance sheet
Working capital swing	Large positive	Smaller positive	Driven by client balance growth, not core working capital

The honest read: strip out client-balance noise and Marex generates roughly $300-450M of "core" free cash flow on $300M of net income — a high-quality 1.0-1.5x conversion ratio supported by minimal capex and modest SBC. The FCF yield of ~16% on the current ~$4.0B market cap is real, even after de-noising client money.

Balance Sheet and Financial Resilience

Marex's balance sheet is the balance sheet of a regulated clearing broker, and standard "Net Debt / EBITDA" arithmetic is not informative. The right lens is regulatory capital, liquidity headroom, and asset quality.

Total assets grew from $2.6B to $34.7B in six years, almost entirely because client balances exploded (a 5.6x rise in clearing client balances since FY2019). The point to internalise: this is clients funding clients, not Marex levering up. Marex's own corporate debt is $5.9B, and most of that — $3.4B current portion of long-term debt — is short-dated funding that sits inside the prime/clearing flow. The truly "for the parent" debt stack is the $500M senior notes issued November 2024 and the additional $500M issued May 2025 (with a third $500M tranche just announced in Q1 2026 ahead of the planned Bermuda redomicile).

Equity has tripled while ROE has tripled — that combination (more capital and better returns on it) is what separates compounders from companies that grow only by raising money.

Goodwill and intangibles total $335M, only ~1% of total assets and ~26% of equity — modest for a company that has done several acquisitions. There is no looming intangible write-down risk.

Returns, Reinvestment, and Capital Allocation

The simplest test of capital allocation is whether equity returns are rising as equity grows. They are.

ROA stays around 1% — a familiar number for a balance-sheet-heavy broker — but ROE has compounded to 27.5% as Marex extracts more profit from each dollar of equity. Management's own preferred metric, Adjusted ROE, was 27.6% for FY2025 and a 34.4% reported / 37.4% adjusted for Q1 2026.

Capital allocation is acquisition-led with a meaningful and growing distribution. FY2025 deployed $242M into M&A (Hamilton Court FX, Winterflood UK market-maker, Agrinvest Brazil agri-broker, Aarna India clearing), $56M into dividends, and $44M into buybacks. Management guided that prior acquisitions are scaling well — Prime Services in particular went from $84M of revenue in FY2024 to $258M in FY2025 (+209%), a clean validation.

Per-share book value has grown ~22% per year despite a 2024 IPO that added shares, and diluted EPS has grown ~40% per year on a 5-year CAGR — meaningful evidence that management is compounding per-share value, not just headcount or revenue.

Segment and Unit Economics

The four operating segments tell different stories. Clearing is the high-margin annuity; Agency & Execution is the growth engine reshaped by Prime; Market Making is the volatility-leveraged option; Solutions is the still-scaling structured-products business.

Where the economics live:

• Clearing carries 49.5% Adj PBT margin (down 350 bps year-over-year because of investment in geographic expansion) — this is the most valuable line of business, not the largest.
• Agency & Execution is the biggest revenue line and the most improved — Adj PBT margin jumped from 15.5% to 26.8% in FY2025 as Prime Services scaled and Hamilton Court FX integrated. Q1 2026 marginally improved further to 28.3%.
• Market Making Q1 2026 Adj PBT was up 232% on volatility — a one-quarter look-through but illustrates the optionality.
• Solutions margin compressed in FY2025 as the segment absorbed higher tech-platform costs; Q1 2026 reaccelerated to 35.2% margin.

A reader's takeaway: Marex's economics are not uniformly distributed. Clearing and Agency & Execution / Prime contribute the bulk of profitability. The thesis depends heavily on whether Prime can hold its newly elevated margin once volatility moderates.

Valuation and Market Expectations

Marex has only two years of public-market history, so a 5- or 10-year valuation series does not exist. What is available is two clean windows: post-IPO 2024 trading versus today.

The current price of $56.51 (May 8, 2026) is just above the $55.12 average analyst target — the bears would say the easy money has been made. The bulls would point to:

• Forward P/E of ~9x consensus for FY2026 (per Yahoo data) on a 27% ROE business.
• 16%+ FCF yield against a 4.5% risk-free rate — even halving for "client money noise" leaves a high-single-digit yield.
• 11-year unbroken track record of sequential adjusted-profit growth.

A simple bear/base/bull frame:

This is not a "cheap stock" trade in the simple sense: the market is paying 9–13x earnings precisely because it doubts the durability of FY2025 margins. Net interest income is already shrinking (−33% in FY2025; Q1 2026 a further −23%). If Prime Services and Hedging Solutions cannot continue to fill that hole with fee/trading income, FY2026 EPS could disappoint. Q1 2026's 21.6% reported PBT margin and continued segment-mix improvement is early evidence that they can.

Peer Financial Comparison

Marex's listed peer set is heterogeneous: a mega-cap electronic broker (IBKR), a US commodities/FCM peer (SNEX), an inter-dealer voice broker (BGC, TCAP), and a principal market-maker (FLOW). All share some part of Marex's value chain; none are a clean comparable on their own.

Currency / disclosure note: market caps shown in trading currency. SNEX revenue is presented as net operating revenue under broker-dealer accounting and is not directly comparable to Marex's gross revenue presentation. IBKR's 77% operating margin reflects an electronics-only model with minimal headcount per dollar of revenue. FCF yields for SNEX/IBKR/FLOW are heavily influenced by client-balance flows — the same caveat that applies to Marex.

The peer pattern: Marex earns the highest ROE in the peer set (27%) at one of the lowest P/E multiples (~13x). Voice IDBs (TCAP, BGC) trade cheap because they are barely growing or losing money; pure principal market-makers (FLOW) trade cheap because revenue is unpredictable; the high-growth, high-margin electronic broker (IBKR) trades at 29x earnings. Marex is growing faster than IBKR (27% vs 20%), at half the P/E (13x vs 29x), with a higher ROE (27% vs 24%) — the obvious caveat being that IBKR's economics are more durable because its margin is structural (technology) rather than cyclical (volatility plus rates).

Marex sits in the lower-right quadrant — fastest-growing peer that is not paying a growth premium. The discount versus IBKR is the work-out potential.

What to Watch in the Financials

What the financials confirm: Marex has a real franchise. Revenue compounds, margins are expanding off a low base, ROE is high, capital is strong, and management is paying down dilution while still buying growth. Cash conversion is genuine once you correct for client-money noise.

What the financials contradict: The "obvious bull case" of peerless cheapness ignores that margin tailwinds (NII, Prime ramp, volatility) are partly cyclical and the share count has crept up (basic +3% Y/Y) despite buybacks because of share-based compensation and IPO-related vesting. Asset growth far outpaces equity growth — a normal feature of a clearing broker, but it does mean any tail risk in client credit gets amplified onto a thin equity base (the $33.9m gas-client default in Q1 2026 is a good warning shot, even though Adjusted PBT still grew 2% in Clearing on a like-for-like basis).

The first financial metric to watch is Agency & Execution's Adjusted PBT margin — specifically whether the 26.8% achieved in FY2025 holds in FY2026 as Prime Services laps its first full year and the FY2025 NII tailwind fades. If that margin sustains, the path opens toward IBKR-style multiples; if it drifts back toward FY2024's 15.5%, the current 9-13x P/E is the right multiple, not a discount.